• Teva wins FDA nod for its generic of Mylan's EpiPen after 2-year delay fiercepharma
    August 20, 2018
    After a delay of more than two years, Teva has won approval of its generic version of Mylan’s highly successful EpiPens. The approval comes at an opportune time given that manufacturing issues have made supplies of Mylan’s epinephrine injectors spotty, le
PharmaSources Customer Service